Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 2/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15038322 | 0.79 | CYP19A1 (0.40) | CYP19A1KDM4EAR | |
| SCHEMBL10705677 | 0.66 | FDPS (0.43) | FDPS | |
| SCHEMBL21580044 | 0.64 | — | — | |
| SCHEMBL22743978 | 0.64 | CYP19A1 (0.43) | CYP19A1KDM4EALDH1A1TSHRAR | |
| SCHEMBL22559038 | 0.64 | CYP19A1 (0.43) | CYP19A1KDM4EALDH1A1TSHRAR | |
| SCHEMBL10704341 | 0.64 | L3MBTL1 (0.57) | FDPS | |
| SCHEMBL15038296 | 0.64 | CYP19A1 (0.43) | CYP19A1KDM4ETSHRFDPS | |
| SCHEMBL15911941 | 0.64 | PGK1 (0.61) | TSHRFDPS | |
| Phosphoric Acid SCHEMBL16176964 | 0.64 | ALDH1A1 (0.73) | KDM4EALDH1A1TSHRFDPS | |
| SCHEMBL22716237 | 0.63 | CYP19A1 (0.42) | CYP19A1KDM4EALDH1A1TSHRAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140339098-A1 | PROCESS AND CATALYST FOR THE ELECTROCHEMICAL REDUCTION OF CARBON DIOXIDE | SOLVAY SA (BE) | 2014-11-20 | — | — | US | disclosed |
| US-20140339098-A1 | PROCESS AND CATALYST FOR THE ELECTROCHEMICAL REDUCTION OF CARBON DIOXIDE | SOLVAY SA (BE) | 2014-11-20 | — | — | US | disclosed |
| WO-2013087792-A2 | PROCESS AND CATALYST FOR THE ELECTROCHEMICAL REDUCTION OF CARBON DIOXIDE | SOLVAY SA (BE) | 2013-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140339098-A1 | PROCESS AND CATALYST FOR THE ELECTROCHEMICAL REDUCTION OF CARBON DIOXIDE | BPGM, CA4, CA6 | CYP19A1 763/4885KDM4E 2607/4885ALDH1A1 2077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.